Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

@article{Mandel1993ReducingMF,
  title={Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.},
  author={J. Mandel and J. Bond and T. Church and D. Snover and G. M. Bradley and L. Schuman and F. Ederer},
  journal={The New England journal of medicine},
  year={1993},
  volume={328 19},
  pages={
          1365-71
        }
}
  • J. Mandel, J. Bond, +4 authors F. Ederer
  • Published 1993
  • Medicine
  • The New England journal of medicine
  • BACKGROUND Although tests for occult blood in the feces are widely used to screen for colorectal cancers, there is no conclusive evidence that they reduce mortality from this cause. We evaluated a fecal occult-blood test in a randomized trial and documented its effectiveness. METHODS We randomly assigned 46,551 participants 50 to 80 years of age to screening for colorectal cancer once a year, to screening every two years, or to a control group. Participants who were screened submitted six… CONTINUE READING
    3,067 Citations

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Colorectal cancer (CRC) is a major cause of death in Sweden. There are approximately 6000 new cases each year in Sweden and the disease specific mortality is more than 40%. There risk is… Expand
    ConditionsColorectal Cancer
    InterventionProcedure
    INTERVENTIONAL CLINICAL TRIAL
    Participants will be mailed an invitation to complete CRC screening along with a fecal immunochemical test (FIT) kit, containing a 1-sample "Polymedco Over the Counter (OC) Sensor… Expand
    ConditionsColorectal Cancer
    InterventionBehavioral
    INTERVENTIONAL CLINICAL TRIAL
    Colorectal Carcinoma (CRC) is the third most frequent diagnosed cancer worldwide, with 1.4 million new cases every year. In an attempt to reduce this number many countries have… Expand
    ConditionsColorectal Adenoma, Colorectal Adenoma and Carcinoma, Colorectal Cancer, (+2 more)
    InterventionDiagnostic Test
    INTERVENTIONAL CLINICAL TRIAL
    This study compares the efficacy (adherence and stage) of four interventions to promote colorectal (CRC) and breast cancer (BC) screenings among women ages 50 to 75. They are: 1… Expand
    ConditionsBreast Cancer Female, Colorectal Cancer
    InterventionBehavioral
    The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    • 1,026
    Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
    • 796
    • PDF
    Population colorectal cancer screening with fecal occult blood test.
    • G. Rennert, H. Rennert, E. Miron, Y. Peterburg
    • Medicine
    • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
    • 2001
    • 46
    • PDF
    Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    • 99
    Fecal occult blood screening in the Minnesota study: sensitivity of the screening test.
    • 89
    • PDF
    Fecal occult blood screening in the Minnesota study: role of chance detection of lesions.
    • 55
    • PDF
    Long-term mortality after screening for colorectal cancer.
    • 542
    • PDF
    Screening for colorectal cancer using the faecal occult blood test, Hemoccult.
    • 485
    • PDF

    References

    SHOWING 1-10 OF 27 REFERENCES
    Occult blood screening for colorectal carcinoma: a critical review.
    • 305
    Colorectal cancer screening.
    • 325
    The design of a study to assess occult-blood screening for colon cancer.
    • 58
    Estimating the duration of ongoing prevention trials.
    • 15